Vulvar cancer epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
 
(34 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Vulvar cancer}}
{{Vulvar cancer}}
{{CMG}}{{AE}}{{MD}}
{{CMG}}{{AE}}{{MD}} {{sali}}
==Overview==
==Overview==
In 2012, the [[incidence]] of  vulvar cancer was estimated to be 2.4 per 100,000 females in the United States.
The [[incidence]] of  vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The [[incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years. Vulvar cancer is more prevalent in the caucasian race.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>


==Epidemiology and Demographics==
==Incidence==
==Incidence==
The [[incidence]]  of vulvar cancer was 2.4 per 100,000 women per year. These rates are age-adjusted and based on 2008-2012 cases and deaths.<ref> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
 
The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>


==Age==
==Age==
*The [[ incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years.<ref> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
*The [[incidence]] of vulvar cancer increases with age; the median age at diagnosis is 68 years.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
|-
|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Age''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''<20''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''20-34''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''35-44''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''45-54'''  || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''55-64'''  || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''65-74''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''75-84''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''>85'''
|-
| style="padding: 0 5px; font-size: 100%; background: #4479BA; color:F5F5F5 ; width: 10%" align=center |'''Incidence'''
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.2%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |6.1%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |15.3%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |19.8%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |19.8%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |22.1%
|style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |14.9%
|}


{| style="cellpadding=0; cellspacing= 0; width: 600px;"
==Race==
* Vulvar cancer is more prevalent in the caucasian race.<ref name=xyz> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center
|-
|-
|style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center | || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Asian/Pacific Islander''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Hispanic''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Black'''
|style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Race''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''All Races''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''White''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Black''' || style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center | '''Asian/Pacific Islander''' ||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''American Indian/Alaska Native'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Hispanic'''||style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Non-Hispanic'''
|-
|-
|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |666.3 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |700.1 per 100,000||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |592.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |510.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |460.5 per 100,000
| style="padding: 0 5px; font-size: 100%; background: #4479BA; color: F5F5F5; width: 10%" align=center |'''Incidence'''|| style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.4 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.6 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |1.8 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |0.9 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.0 per 100,000 || style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |1.7 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #DCDCDC" align=center |2.5 per 100,000  
| style="padding: 0 5px; font-size: 100%; background: #4682B4; color: #FFFFFF; width: 10%" align=center |'''Age Incidence'''|| style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |666.3 per 100,000 ||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |700.1 per 100,000||style="font-size: 100; padding: 0 5px; background: #B8B8B8" align=left |592.9 per 100,000
|}
|}


==Race==
* Vulvar cancer is more prevalent in the white race.<ref> SEER Stat Fact Sheets: Vulvar Cancer.  Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015</ref>
==References==
==References==
{{Reflist|2}}
{{Reflist|1}}
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Gynecology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Gynecology]]

Latest revision as of 19:56, 10 April 2019

Vulvar cancer Microchapters

Home

Patient Info

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vulvar cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vulvar cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vulvar cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vulvar cancer epidemiology and demographics

CDC on Vulvar cancer epidemiology and demographics

Vulvar cancer epidemiology and demographics in the news

Blogs on Vulvar cancer epidemiology and demographics

Directions to Hospitals Treating Vulvar cancer

Risk calculators and risk factors for Vulvar cancer epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Monalisa Dmello, M.B,B.S., M.D. [2] Syed Musadiq Ali M.B.B.S.[3]

Overview

The incidence of vulvar cancer was estimated to be 2.4 per 100,000 females in the United States. The incidence of vulvar cancer increases with age; the median age at diagnosis is 68 years. Vulvar cancer is more prevalent in the caucasian race.[1]

Epidemiology and Demographics

Incidence

The overall age adjusted incidence rate of vulvar cancer among females is approximately 2.4 per 100,000 individuals in the United States.[1]

Age

  • The incidence of vulvar cancer increases with age; the median age at diagnosis is 68 years.[1]
Age <20 20-34 35-44 45-54 55-64 65-74 75-84 >85
Incidence 0.2% 2% 6.1% 15.3% 19.8% 19.8% 22.1% 14.9%

Race

  • Vulvar cancer is more prevalent in the caucasian race.[1]
Race All Races White Black Asian/Pacific Islander American Indian/Alaska Native Hispanic Non-Hispanic
Incidence 2.4 per 100,000 2.6 per 100,000 1.8 per 100,000 0.9 per 100,000 2.0 per 100,000 1.7 per 100,000 2.5 per 100,000

References

  1. ↑ 1.0 1.1 1.2 1.3 SEER Stat Fact Sheets: Vulvar Cancer. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/statfacts/html/vulva.html Accessed on September 21, 2015
Retrieved from "https://www.wikidoc.org/index.php?title=Vulvar_cancer_epidemiology_and_demographics&oldid=1562511"